Eucalyptus essential oil (1,8-cineole)

EMA Well-Established Use monograph for cough associated with a cold; a standardised 1,8-cineole capsule eased symptoms of acute rhinosinusitis in one RCT.

Evidence
Preliminary evidenceGRADE certainty: Low
Typical dose
Standardised enteric-coated 1,8-cineole capsule: 200 mg three times daily for 7–14 days acute use
Time to effect
Symptom relief often within 4–7 days
Safety
Has documented cautions

Evidence ratings summarise published research on Eucalyptus essential oil (1,8-cineole) in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about Eucalyptus essential oil (1,8-cineole)

Interactions

Taking any medication?

Check Eucalyptus essential oil (1,8-cineole) against it.

Why

Eucalyptus globulus essential oil, and the principal monoterpene 1,8-cineole (eucalyptol), holds an EMA HMPC monograph at Well-Established Use for cough associated with cold. In one double-blind RCT (n=152) in acute nonpurulent rhinosinusitis, cineole capsules (two 100 mg capsules three times daily) lowered a symptom score more than placebo at 4 and 7 days, with two mild side effects. Inhalation use as steam or chest rub is the traditional form.

How it works

1,8-cineole has secretolytic (mucus-loosening) and modest antibacterial effects on respiratory epithelium. Inhibits NF-κB and reduces leukotriene synthesis, anti-inflammatory action in airway mucosa. Activates TRPM8 cold-receptors, basis of the cooling sensation.

Expected onset · Symptom relief often within 4–7 days

How to take

Dosage

Standardised enteric-coated 1,8-cineole capsule: 200 mg three times daily for 7–14 days acute use. Inhalation: 2–3 drops in hot water, breathe vapour 2–3 times daily.

Timing

Three times daily during symptomatic phase

On the label

Standardised enteric-coated 1,8-cineole capsules are the form with RCT evidence. Generic eucalyptus oil is not equivalent for internal use.

Studied in

Adults with cough associated with a cold, or acute rhinosinusitis.

Safety

Internal use of essential oil only as enterically coated standardised capsule; raw essential oil drunk is dangerous (overdose: CNS depression, seizures). Topical use diluted only. Undiluted is dermal irritant. The EMA contraindicates eucalyptus oil in children under 30 months (risk of laryngospasm) and in children with a history of seizures; oral use is for 12 years and over, inhalation and skin use from 4 years. Pregnancy: avoid medicinal doses. Caution in asthma, paradoxical bronchospasm has been reported.
Loading interactions…

Evidence

At a glance

Kehrl 2004 Laryngoscope RCT (n=152, acute nonpurulent rhinosinusitis): cineole capsules (two 100 mg capsules three times daily) lowered the symptom score more than placebo at 4 and 7 days, with two mild side effects reported. The EMA also lists eucalyptus oil as a well-established use for cough associated with a cold. Neither addressed preventing colds.

GRADE certainty: Low — rated by Healicus using the GRADE method

Questions people ask

Does Eucalyptus essential oil (1,8-cineole) work?

Kehrl 2004 Laryngoscope RCT (n=152, acute nonpurulent rhinosinusitis): cineole capsules (two 100 mg capsules three times daily) lowered the symptom score more than placebo at 4 and 7 days, with two mild side effects reported. The EMA also lists eucalyptus oil as a well-established use for cough associated with a cold. Neither addressed preventing colds. Certainty of the evidence: Low, rated by Healicus using the GRADE method.

How is Eucalyptus essential oil (1,8-cineole) taken?

Standardised enteric-coated 1,8-cineole capsule: 200 mg three times daily for 7–14 days acute use. Inhalation: 2–3 drops in hot water, breathe vapour 2–3 times daily. Timing: Three times daily during symptomatic phase. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

Internal use of essential oil only as enterically coated standardised capsule; raw essential oil drunk is dangerous (overdose: CNS depression, seizures). Topical use diluted only. Undiluted is dermal irritant. The EMA contraindicates eucalyptus oil in children under 30 months (risk of laryngospasm) and in children with a history of seizures; oral use is for 12 years and over, inhalation and skin use from 4 years. Pregnancy: avoid medicinal doses. Caution in asthma, paradoxical bronchospasm has been reported. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: EMA HMPC monograph, Eucalyptus globulus Labill. (and other Eucalyptus species), aetheroleum (Well-Established Use + Traditional Use); Kehrl W et al., Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial, Laryngoscope 2004.

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.